Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025)

Achieve Life Sciences' (ACHV) quarterly Exchange Rate Effect came in at $4000.0 in Q4 2025, up 300.0% on a QoQ basis from -$2000.0 in Q1 2025.

Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025) Analysis & Trends

Achieve Life Sciences (ACHV) has 13 years of Exchange Rate Effect data on file, last reported at $4000.0 in Q4 2025.

Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3000.0 (changed N/A YoY) and the FY2025 annual result came in at $3000.0, changed N/A from the prior year.
Exchange Rate Effect climbed to $4000.0 in Q4 2025, from -$2000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $4000.0 in Q4 2022 to a low of -$3000.0 in Q3 2021.
A 4-year average of $428.57 and a median of -$1000.0 in 2022 frame the typical range for Exchange Rate Effect.
The widest YoY moves for Exchange Rate Effect: up 0.0% in 2023, down 0.0% in 2023.
Tracing ACHV's Exchange Rate Effect over 4 years: stood at -$3000.0 in 2021, then soared by 233.33% to $4000.0 in 2022, then slumped by 50.0% to $2000.0 in 2023, then surged by 100.0% to $4000.0 in 2025.
The last three Exchange Rate Effect figures came in at $4000.0 (Q4 2025), -$2000.0 (Q1 2025), and $2000.0 (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-300,000.00
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	19.84 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-14,590.12
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-2.45 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-287,000.00
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-	-

Download Data